Evaluation of inflammatory and oxidative profile in patients with recurrent wheezing
DOI:
https://doi.org/10.5902/2179460X43362Palavras-chave:
Wheezing, Inflammation, Oxidative stress, AsthmaResumo
Wheezing is a clinical expression of numerous respiratory-related conditions. Although asthma is the leading cause of wheezing during childhood. The present study aims to evaluate the inflammatory and oxidative profile of pediatric patients with recurrent wheezing. Seventy-eight volunteers were divided into three groups according to their age (≤ 36, 36 to 72 and ≥ 73 months). Blood was collected for hematological evaluation, serum detections of total immunoglobulin E (IgE), and C-reactive protein (PCRus). The oxidative profile was evaluated by total antioxidant capacity (FRAP), malondialdehyde (MDA) and carbonylated protein markers. There was no significant difference in the IgE and PCRus levels among the three groups evaluated. However, a significant positive correlation was observed for PCRus with total leukocyte and with neutrophils for the group of patients ≥ 73 months of age. The intermediate age group presented significantly reduced FRAP values in the serum, while significant values of oxidative damage markers were observed in the group of patients ≥ 73 months of age. When determining the correlation between inflammatory and oxidative markers, only the ≥ 73 months group showed significant. The group ≥ 73 months stands out with significant alterations of the oxidative stress markers and their correlations with the inflammatory profile.
Downloads
Referências
AKIIBINU MO, KOLAWOLE TO. Markers of Oxidative Stress and C-reactive Protein Levels in Asthmatics. Journal of Medicine and Medical Sciences. 2014;5(4),93–6.
AMAT F, VIAL A, PEREIRA B, PETIT I, LABBE A, JUST J. Predicting the long-term course of asthma in wheezing infants is still a challenge. ISRN Allergy. 2011;27:493624.
BENZIE I; STRAIN J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power: The FRAP Assay”. Analytical Biochemistry. 1996;70-76.
BOSTANCI I, OZMEN S, SEN HS, DIBEK EM, ZORLU P. Importance of high sensitivity C-reactive protein in the evaluation of wheezing in children. Pediatrics International. 2016;58,1101-4.
BOUSQUET J, VIGNOLA AM, DEMOLY P. Links between rhinitis and asthma. Allergy. 2003;58(8):691-706.
BOZAYKUT A, PAKETCIB A, SEZERA RG, PAKETCIC C. Evaluation of Risk Factors for Recurrent Wheezing Episodes. Journal of Clinical Medicine Research. 2013;5(5):395-400.
BURGESS SL, LU M, MA JZ, NAYLOR C, DONOWITZ JR, KIRKPATRICK BD, HAQUE R, PETRI WA. Inflammatory markers predict episodes of wheezing during the first year of life in Bangladesh. Respir Med. 2016;110:53–7.
CARLSEN KH. What distinguishes the asthmatic amongst the infant wheezers? Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology. 1997;8:(10),40–5.
DUCHARME, FM, TSE SM, CHAUHAN B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014;383(9928):1593-604.
FERRIANI VPL, SILVA JM, CAMARA AA, TOBIAS KR, MACEDO M, CARDOSO R, ARRUDA E, PLATTS-MILLS TAE, ARRUDA LK. Risk factors for persistent whezzing in young children. Journal of Allergy and Clinical Immunology. 2004;113(2):S97.
FROIDURE A, MOUTHUY J, DURHAM SR, CHANEZ P, SIBILLE Y, PILETTE C. Asthma phenotypes and IgE responses. European Respiratory Journal. 2016;47(1):304-19.
FUJITA M, UEKI S, ITO W, CHIBA T, TAKEDA M, SAITO N, KAYABA H, CHIHARA J. C-reative protein levels in the serum of asthmatic patients. Ann Allergy Asthma Immunol. 2007;99(1):48-53.
GÜNAZ E, SARINÇ US, AKAR O, AHSEN A, GÜNAY S, KOYUNCU T, ÜNLÜ M. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: A retrospective study. Inflammation. 2014;37(2):374-80.
GUNGEN AC, AYDEMIR Y. The correlation between asthma disease and neutrophil to lymphocyte ratio. Research Journal of Allergy and Immunology. 2017;1(1),1-4.
HAUBER HP, HAMID Q. The role of interleukin-9 in asthma. Allergology International. 2005;54(1)71-8.
JESENAK M, ZELIESKOVA M, BABUSIKOVA E. Oxidative Stress and Bronchial Asthma in Children—Causes or Consequences? Frontiers in Pediatrics. 2017;24(5):1-8.
JIANG C, HU H, ZHU W, XU J, LOU B, SUN Q, YANG X, MENG L, LU S. Neutrophil–Lymphocyte Ratio in Children with Recurrent Wheezing. Pediatric Allergy, Immunology and Pulmonology. 2017;30(4).
KLENIEWSKA P, PAWLICZAK R. The participation of oxidative stress in the pathogenesis of bronchial asthma. Biomed Pharmacother. 2017;94:100-8.
KLINNERT MD, PRICE MR, LIU AH, ROBINSON JL. Morbidity patterns among low-income wheezing infants. Pediatrics. 2003;112:49-57.
KURUTAS EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutrition Journal. 2016;15:71.
LANNERÖ E, WICKMAN M, PERSHANGEN G, NORDVALL L. Maternal smoking during pregnancy increases the risk of recurrent wheezing during the first years of life. Respiratoty Research. 2006;7(3):1-6.
LASSO-PIROT A, DELGADO-VILLALTA S, SPANIER AJ. Early childhood wheezers: identifying asthma in later life. J Asthma Allergy. 2015;13(8):63-73.
LIVNAT G, YOSEPH RB, NIR V, HAKIM F, YIGLA M, BENTUR L. Evaluation of High-Sensitivity Serum CRP Levels Compared to Markers of Airway Inflammation and Allergy as Predictors of Methacholine Bronchial Hyper-Responsiveness in Children. Lung. 2015;193(1):39-45.
MARTINEZ FD, WRIGHT AL, TAUSSIG LM, HOLBERG CJ, HALONEM M, MORGAN WJ. Asthma and Wheezing in the First Six Years of Life. New England Journal of Medicine. 1995;332(3):133-8.
NACAROGLU HT, ISGÜDER R, BENT S, ERDEM BS, CEYLAN G, KORKMAZ HA, CAN D. Can neutrophil/lymphocyte ratio be a novel biomarker of inflammation in children with asthma? European Journal of Inflammation. 2016;4(2):109-12.
RADOVIC J, VOJINOVIC J, BOJANIC V, JECTOVIC ST, KOCICS G, MILOJKOVIC M, PAVLOVIC D. Lipid peroxidation and oxidative protein products in children with episodic fever of unknown origin. Journal of Medical Biochemistry. 2013;33(2), 197–202.
RAHMAN I, BISWAS SK, KODE A. Oxidant and antioxidant balance in the airways and airway diseases. European Journal of Pharmacology. 2006;533(1-3):222-39.
SAHOO RC, ACHARYA PR, NOUSHAD TH, ANAND R, ACHARYA VK, SAHU KR. A study of high-sensitivity C-reactive protein in bronchial asthma. Indian J Chest Dis Allied Sci. 2009;51(4), 213–216.
SHERRILL DL, STEIN R, HALONEN M, HOLBERG CJ, WRIGHT A, MARTINEZ FD. Total serum IgE and its association with asthma symptoms and allergic sensitization among children. J Allergy Clin Immunol. 1999,104(1):28036.
SINGH YA, SAINI M. Evaluation of Systemic Antioxidant Level and Oxidative Stress In Relation to Lifestyle and Disease Progression in Asthmatic Patients. Journal of Medical Biochemistry. 2016;35(1), 55–62.
SOTO-QUIROS M, AVILA L, PLATTS-MILLS TAE, HUNT JF, ERDMAN DD, CARPER H, MURPHY DD, ODIO S, JAMES HR, PATRIE JT, HUNT W, O’ROURKE AK, DAVIS MD, STEINKE JW, LU X, KENNEDY J, HEYMANN PW. High Titers of IgE Antibody to Dust Mite Allergen and the Risk for Wheezing Among Asthmatic Children Infected with Rhinovirus. J Allergy Clin Immunol. 2012;129(6):1499–505.
SPEIGHT AN, LEE DA, HEY EN. Underdiagnosis and undertreatment of asthma in childhood. British Medical Journal. 1983;286(6373),1253–6.
WANG FP, LIU T, LAN Z, LI SY, MAO H. Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: a systematic review and meta-analysis. Plos One. 2016;22(11).
WRIGHT A L. Epidemiology of asthma and recurrent wheeze in childhood. Clinical Reviews in Allergy and Immunology. 2002;22(1):33-44.
Downloads
Publicado
Versões
- 2022-04-06 (2)
- 2021-05-18 (1)
Como Citar
Edição
Seção
Licença
Copyright (c) 2020 Ciência e Natura
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Para acessar a DECLARAÇÃO DE ORIGINALIDADE E EXCLUSIVIDADE E CESSÃO DE DIREITOS AUTORAIS clique aqui.
Diretrizes Éticas para Publicação de Revistas
A revista Ciência e Natura está empenhada em garantir a ética na publicação e na qualidade dos artigos.
A conformidade com padrões de comportamento ético é, portanto, esperada de todas as partes envolvidas: Autores, Editores e Revisores.
Em particular,
Autores: Os Autores devem apresentar uma discussão objetiva sobre a importância do trabalho de pesquisa, bem como detalhes e referências suficientes para permitir que outros reproduzam as experiências. Declarações fraudulentas ou intencionalmente incorretas constituem comportamento antiético e são inaceitáveis. Artigos de Revisão também devem ser objetivos, abrangentes e relatos precisos do estado da arte. Os Autores devem assegurar que seu trabalho é uma obra totalmente original, e se o trabalho e / ou palavras de outros têm sido utilizadas, isso tem sido devidamente reconhecido. O plágio em todas as suas formas constitui um comportamento publicitário não ético e é inaceitável. Submeter o mesmo manuscrito a mais de um jornal simultaneamente constitui um comportamento publicitário não ético e é inaceitável. Os Autores não devem submeter artigos que descrevam essencialmente a mesma pesquisa a mais de uma revista. O Autor correspondente deve garantir que haja um consenso total de todos os Co-autores na aprovação da versão final do artigo e sua submissão para publicação.
Editores: Os Editores devem avaliar manuscritos exclusivamente com base no seu mérito acadêmico. Um Editor não deve usar informações não publicadas na própria pesquisa do Editor sem o consentimento expresso por escrito do Autor. Os Editores devem tomar medidas de resposta razoável quando tiverem sido apresentadas queixas éticas relativas a um manuscrito submetido ou publicado.
Revisores: Todos os manuscritos recebidos para revisão devem ser tratados como documentos confidenciais. As informações ou ideias privilegiadas obtidas através da análise por pares devem ser mantidas confidenciais e não utilizadas para vantagens pessoais. As revisões devem ser conduzidas objetivamente e as observações devem ser formuladas claramente com argumentos de apoio, de modo que os Autores possam usá-los para melhorar o artigo. Qualquer Revisor selecionado que se sinta desqualificado para rever a pesquisa relatada em um manuscrito ou sabe que sua rápida revisão será impossível deve notificar o Editor e desculpar-se do processo de revisão. Os Revisores não devem considerar manuscritos nos quais tenham conflitos de interesse resultantes de relacionamentos ou conexões competitivas, colaborativas ou outras conexões com qualquer dos autores, empresas ou instituições conectadas aos documentos.
